Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$113.62 - $135.39 $261,326 - $311,396
2,300 Added 54.76%
6,500 $846,000
Q2 2024

Aug 13, 2024

SELL
$89.48 - $118.35 $80,532 - $106,515
-900 Reduced 17.65%
4,200 $497,000
Q1 2024

May 14, 2024

SELL
$76.4 - $96.33 $15,280 - $19,266
-200 Reduced 3.77%
5,100 $480,000
Q4 2023

Feb 13, 2024

BUY
$59.53 - $85.11 $303,603 - $434,061
5,100 Added 2550.0%
5,300 $421,000
Q3 2023

Nov 13, 2023

BUY
$69.23 - $79.09 $13,846 - $15,818
200 New
200 $15,000
Q4 2022

Feb 10, 2023

SELL
$40.82 - $57.75 $420,446 - $594,825
-10,300 Reduced 91.96%
900 $39,000
Q2 2022

Aug 12, 2022

BUY
$34.86 - $63.77 $383,460 - $701,470
11,000 Added 5500.0%
11,200 $509,000
Q1 2022

May 13, 2022

BUY
$44.33 - $57.82 $8,866 - $11,564
200 New
200 $12,000
Q2 2021

Aug 13, 2021

SELL
$73.06 - $97.7 $409,136 - $547,120
-5,600 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$70.43 - $97.42 $394,408 - $545,552
5,600 New
5,600 $470,000
Q2 2020

Aug 14, 2020

SELL
$28.78 - $46.83 $431,700 - $702,450
-15,000 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$25.53 - $70.14 $293,595 - $806,610
11,500 Added 328.57%
15,000 $463,000
Q4 2019

Feb 13, 2020

BUY
$54.18 - $65.64 $27,090 - $32,820
500 Added 16.67%
3,500 $191,000
Q3 2019

Nov 08, 2019

BUY
$58.58 - $83.91 $152,308 - $218,166
2,600 Added 650.0%
3,000 $188,000
Q1 2019

May 15, 2019

SELL
$50.75 - $80.54 $243,600 - $386,592
-4,800 Reduced 92.31%
400 $31,000
Q4 2018

Feb 13, 2019

BUY
$52.18 - $67.93 $177,412 - $230,962
3,400 Added 188.89%
5,200 $292,000
Q3 2018

Nov 13, 2018

BUY
$38.13 - $68.37 $68,634 - $123,066
1,800 New
1,800 $117,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.85B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.